Dent’s disease is a rare genetic kidney disorder that primarily affects males, leading to progressive kidney damage and often kidney failure. Treatment focuses on protecting kidney function, preventing complications like kidney stones, and managing symptoms such as bone problems. While there is no cure that addresses the underlying genetic cause, a combination of supportive therapies and lifestyle modifications can help slow disease progression and improve quality of life.

Understanding Treatment Goals for Dent’s Disease

The treatment approach for Dent’s disease aims to preserve kidney function for as long as possible and prevent serious complications. Because this disorder affects the tiny tubes inside the kidneys called proximal tubules, which normally help reabsorb important substances back into the blood, patients lose vital minerals and proteins through their urine. This loss creates a cascade of problems throughout the body that require careful management.

Medical professionals recognize that Dent’s disease varies greatly from one person to another, even within the same family. Some individuals experience only mild symptoms that may go unnoticed for years, while others develop severe kidney problems in childhood. This variability means that treatment must be tailored to each patient’s specific symptoms and disease severity. The age at which symptoms appear, the rate of kidney function decline, and the presence of complications like kidney stones or bone disease all influence treatment decisions.^[1][2]

Currently, medical societies recommend supportive care focused on managing symptoms rather than correcting the underlying genetic defect. Treatment strategies include reducing calcium loss in the urine to prevent kidney stones, supplementing vitamins and minerals that are lost, and monitoring kidney function closely. The goal is to delay the progression to end-stage renal disease, a life-threatening condition where the kidneys can no longer filter waste products from the body effectively. Approximately thirty to eighty percent of affected males develop end-stage renal disease between ages thirty and fifty, though some individuals maintain adequate kidney function well into their sixties or beyond.^[2][5]

Standard Medical Treatment Approaches

The cornerstone of standard treatment for Dent’s disease involves managing hypercalciuria, which means having excessive calcium in the urine. This condition is found in more than ninety-five percent of patients and is a major contributor to the formation of kidney stones and calcium deposits within the kidney tissue itself. Without intervention, these calcium deposits can damage kidney tissue and accelerate the decline in kidney function.

One common medication used to reduce calcium in the urine is a class of drugs called thiazide diuretics, with hydrochlorothiazide being a frequently prescribed example. These medications work by changing how the kidney tubules handle sodium and calcium, ultimately leading to less calcium being excreted in the urine. While thiazide diuretics can effectively lower urinary calcium levels in boys and men with Dent’s disease, their use is often limited by side effects. These medications can cause the body to lose potassium, a mineral essential for heart and muscle function, leading to a condition called hypokalemia. Patients taking thiazide diuretics may need to have their blood potassium levels monitored regularly and may require potassium supplements to maintain healthy levels.^[2][4][6]

For patients who develop bone problems, treatment involves supplementing with vitamin D and phosphorus. Dent’s disease can lead to rickets in children or osteomalacia in adults, conditions where bones become weak and soft due to low levels of vitamin D and minerals like calcium and phosphorus in the blood. This happens because the damaged kidney tubules fail to reabsorb phosphate properly, and vitamin D metabolism becomes impaired. When these substances are lost in the urine instead of being recycled by the body, bones cannot maintain their normal strength and structure. Dietary supplementation with vitamin D and phosphorus can help restore healthy bone development and prevent painful bone deformities.^[2][6][12]

Other substances lost in the urine may also need replacement. Some patients require supplements of phosphate, bicarbonate, or citrate depending on their individual laboratory findings. Citrate is particularly important because it helps prevent kidney stones from forming. When kidney stones do develop, they may require surgical removal, especially if they cause blockages in the urinary system or severe pain. Modern surgical techniques are less invasive than traditional open surgery and allow for faster recovery.^[6][12]

The role of medications that block the renin-angiotensin system, such as angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, remains unclear in Dent’s disease. These medications are sometimes used in other kidney diseases to reduce protein loss in the urine and slow the progression of kidney damage. However, their effectiveness specifically for children with Dent’s disease and protein in the urine has not been clearly established through controlled trials. Doctors may consider these medications on a case-by-case basis, weighing potential benefits against the lack of definitive evidence.^[2]

When kidney function deteriorates to the point of end-stage renal disease, renal replacement therapy becomes necessary for survival. This can take the form of dialysis, where a machine filters waste products from the blood, or kidney transplantation, where a healthy donor kidney is surgically placed in the body to replace the failed kidneys. Kidney transplantation is often preferred when feasible because it provides better quality of life and longer survival compared to long-term dialysis. The disease does not recur in the transplanted kidney because the new kidney does not carry the genetic mutation that caused the original kidney damage.^[2][6]

Lifestyle Measures and Preventive Care

Beyond medications, lifestyle modifications play a crucial role in managing Dent’s disease and preserving kidney function. Patients are strongly encouraged to maintain good hydration by drinking plenty of fluids throughout the day. Adequate fluid intake helps dilute the urine, reducing the concentration of calcium and other substances that can form kidney stones. This simple measure can significantly decrease the risk of stone formation.

Following a low-salt diet is another important preventive strategy. High sodium intake increases calcium excretion in the urine, worsening the already elevated calcium levels seen in Dent’s disease. By reducing dietary salt, patients can help lower urinary calcium and decrease the likelihood of developing kidney stones and calcium deposits in kidney tissue. Healthcare providers may recommend working with a dietitian to develop a meal plan that restricts sodium while ensuring adequate nutrition.^[7][10][17]

Regular monitoring is essential for all patients with Dent’s disease, regardless of symptom severity. At least annual checkups should include urine tests to measure protein and calcium levels, blood tests to assess kidney function and electrolyte balance, and blood pressure measurements. Imaging studies such as ultrasound may be performed periodically to check for kidney stones or calcium deposits. This surveillance allows healthcare providers to detect changes early and adjust treatment accordingly.^[2]

Some children with Dent’s disease experience growth failure, meaning they do not grow at the expected rate for their age. In these cases, treatment with human growth hormone may be considered. Studies suggest that growth hormone therapy can improve height without adversely affecting kidney function, though this treatment should be carefully supervised by specialists experienced in both growth disorders and kidney disease.^[2]

Investigational Approaches and Future Treatment Possibilities

Because there are no standardized treatment protocols or guidelines specifically developed for Dent’s disease, and because the disorder is so rare, no large-scale treatment trials have been conducted to test new therapies. The rarity of the condition, with only about two hundred and fifty affected families reported worldwide, makes it challenging to organize clinical studies with enough participants to draw reliable conclusions about treatment effectiveness.^[7][10]

The scientific understanding of Dent’s disease has advanced significantly since the genes responsible for the condition were discovered. Dent disease type 1 is caused by mutations in the CLCN5 gene, which provides instructions for making a protein that acts as a chloride-proton exchanger in kidney cells. This protein helps maintain the proper environment inside cellular compartments called endosomes, which are essential for recycling proteins and other molecules. When this protein does not work correctly, the kidney tubules cannot properly reabsorb proteins, calcium, and other important substances from the urine. Dent disease type 2 results from mutations in the OCRL gene, which encodes an enzyme involved in processing certain fat molecules in cell membranes. This enzyme also plays a role in the normal function of endosomes and protein recycling.^[1][4][5]

Researchers continue to investigate the precise mechanisms by which these genetic mutations lead to kidney damage. Understanding exactly how the defective proteins disrupt kidney cell function could reveal new targets for drug development. For instance, if scientists could identify other molecules that compensate for the missing or defective protein, they might develop therapies to enhance those compensatory mechanisms.

Interestingly, about twenty-five percent of individuals who meet the clinical criteria for Dent’s disease do not have identifiable mutations in either the CLCN5 or OCRL gene. This finding suggests that at least one additional gene, not yet discovered, can cause a similar disease when mutated. Identifying this third gene would expand our understanding of kidney tubule function and might reveal additional therapeutic targets. It could also lead to the development of genetic tests that can diagnose all cases of Dent’s disease, not just those caused by the two currently known genes.^[1][4][7]

Gene therapy, an approach where functional copies of a defective gene are introduced into a patient’s cells, represents a potential future treatment avenue. In theory, delivering a working copy of the CLCN5 or OCRL gene to kidney tubule cells could restore normal protein and mineral reabsorption. However, gene therapy for kidney diseases faces significant technical challenges. The kidneys are complex organs with many different cell types, and delivering genetic material specifically to the affected proximal tubule cells is difficult. Additionally, the therapy would need to maintain long-term expression of the corrected gene to provide lasting benefit. While gene therapy has shown promise for some genetic disorders, it remains experimental for Dent’s disease and is not currently available outside of research settings.

Most Common Treatment Methods

• Medications to Reduce Urinary Calcium
  • Thiazide diuretics such as hydrochlorothiazide are used to decrease calcium excretion in the urine and prevent kidney stone formation
  • Side effects include potassium loss, requiring monitoring and possible supplementation
• Nutritional Supplementation
  • Vitamin D supplements to prevent and treat bone problems like rickets and osteomalacia
  • Phosphorus replacement to correct low blood phosphate levels and support bone health
  • Bicarbonate supplementation if acid-base balance is disrupted
  • Citrate supplements to help prevent kidney stone formation
• Lifestyle and Dietary Modifications
  • Maintaining high fluid intake to dilute urine and reduce stone formation
  • Following a low-salt diet to decrease calcium loss in urine
  • Avoiding kidney-toxic medications including NSAIDs and certain antibiotics
• Surgical Interventions
  • Minimally invasive procedures to remove kidney stones when they cause blockages or pain
  • Treatment typically involves collaboration between urology, radiology, and nephrology specialists
• Renal Replacement Therapy
  • Dialysis to filter waste products from blood when kidneys fail
  • Kidney transplantation offers better long-term outcomes than dialysis for end-stage renal disease
• Supportive Treatments
  • Human growth hormone for children with growth failure
  • Regular monitoring of kidney function, electrolytes, blood pressure, and bone health

Special Considerations for Different Types of Dent’s Disease

Dent disease type 2, caused by mutations in the OCRL gene, can present with additional features beyond kidney problems. Unlike Dent disease type 1, which affects only the kidneys, type 2 may be associated with mild intellectual disability, clouding of the eye lenses called cataracts that usually do not affect vision, and reduced muscle tone known as hypotonia. Affected individuals may also have elevated levels of certain muscle enzymes in their blood, including creatine phosphokinase and lactate dehydrogenase, even without obvious muscle disease. These enzyme elevations help doctors distinguish Dent disease type 2 from type 1 when genetic testing results are pending.^[1][13]

The OCRL gene mutations that cause Dent disease type 2 are closely related to those causing a more severe condition called Lowe syndrome, also known as oculocerebrorenal syndrome. Lowe syndrome is characterized by severe intellectual disability, profound muscle weakness, serious eye abnormalities including congenital cataracts that impair vision, and kidney disease similar to Dent’s disease. Some researchers consider Dent disease type 2 to represent the mild end of a spectrum, with Lowe syndrome at the severe end. The distinction between these conditions sometimes becomes blurred when an individual with an OCRL mutation has features intermediate between the two. Treatment for the extra-kidney manifestations of Dent disease type 2 may require involvement of additional specialists such as ophthalmologists for eye problems and developmental specialists for learning difficulties.^[1][13]

Living With Dent’s Disease and Long-Term Outlook

The course of Dent’s disease varies considerably, and predicting outcomes for any individual patient remains challenging. Some men maintain normal or near-normal kidney function throughout their lives with appropriate management, while others progress to kidney failure relatively early in adulthood. Factors that may influence the rate of progression include the specific genetic mutation involved, how early treatment is started, success in preventing kidney stones and calcium deposits, and overall health status including blood pressure control.

Psychological and emotional support represents an important, though often overlooked, aspect of comprehensive care. Living with a chronic progressive disease can be stressful for patients and families. Children may struggle with restrictions on their activities or dietary limitations. Adults may worry about job security, insurance coverage, and the possibility of needing dialysis or transplantation. Connecting with support groups or speaking with counselors experienced in chronic kidney disease can help patients and families cope with these challenges.

Research registries play a valuable role in advancing knowledge about rare diseases like Dent’s disease. By enrolling in a registry, patients contribute their health information to a database that researchers can access to study disease patterns, outcomes, and treatment responses. These registries can accelerate the discovery of new treatments by making it easier to identify potential participants for clinical trials and by revealing patterns that might not be apparent in small individual studies. Several international registries specifically focused on rare kidney diseases, including Dent’s disease, are currently active and accepting participants.

As medical understanding of Dent’s disease continues to expand and new treatment approaches are developed, maintaining regular contact with healthcare providers who have experience with rare kidney disorders is essential. Specialists in pediatric or adult nephrology, particularly those associated with academic medical centers or rare disease networks, are most likely to be familiar with the latest research findings and emerging therapies.